PRL2 regulates neutrophil extracellular trap formation which contributes to severe malaria and acute lung injury.
Xinyue DuBaiyang RenChang LiQi LiShuo KanXin WangWenjuan BaiChenyun WuKokouvi KassegneHuibo YanXiaoyin NiuMin YanWenyue XuSamuel Crocodile WassmerJing WangGuangjie ChenZhao-Jun WangPublished in: Nature communications (2024)
Excessive host immune responses contribute to severe malaria with high mortality. Here, we show that PRL2 in innate immune cells is highly related to experimental malaria disease progression, especially the development of murine severe malaria. In the absence of PRL2 in myeloid cells, Plasmodium berghei infection results in augmented lung injury, leading to significantly increased mortality. Intravital imaging revealed greater neutrophilic inflammation and NET formation in the lungs of PRL2 myeloid conditional knockout mice. Depletion of neutrophils prior to the onset of severe disease protected mice from NETs associated lung injury, and eliminated the difference between WT and PRL2 CKO mice. PRL2 regulates neutrophil activation and NET accumulation via the Rac-ROS pathway, thus contributing to NETs associated ALI. Hydroxychloroquine, an inhibitor of PRL2 degradation alleviates NETs associated tissue damage in vivo. Our findings suggest that PRL2 serves as an indicator of progression to severe malaria and ALI. In addition, our study indicated the importance of PRL2 in NET formation and tissue injury. It might open a promising path for adjunctive treatment of NET-associated disease.
Keyphrases
- plasmodium falciparum
- immune response
- early onset
- oxidative stress
- bone marrow
- dendritic cells
- acute myeloid leukemia
- drug induced
- cardiovascular events
- cell death
- cardiovascular disease
- risk factors
- minimally invasive
- high resolution
- high fat diet induced
- lipopolysaccharide induced
- toll like receptor
- mass spectrometry
- metabolic syndrome
- weight gain
- inflammatory response
- photodynamic therapy
- insulin resistance
- mouse model
- replacement therapy
- skeletal muscle
- combination therapy
- virtual reality